Cargando…

Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis

BACKGROUND AND AIM: It is unclear how adding an anti‐tumor necrosis factor alpha agent to immunomodulator (IM) treatment, as a step‐up strategy, affects long‐term outcomes in ulcerative colitis. This retrospective study investigated persistence associated with biologic anti‐tumor necrosis factor alp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Taku, Udagawa, Eri, Uda, Akihito, Hibi, Toshifumi, Hisamatsu, Tadakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Gastroenterology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027773/ https://www.ncbi.nlm.nih.gov/pubmed/31397010 http://dx.doi.org/10.1111/jgh.14825

Ejemplares similares

Ulcerative colitis outcomes research in Japan: protocol for an observational prospective cohort study of YOURS (YOu and Ulcerative colitis: Registry and Social network)
por: Yamazaki, Hajime, et al.
Publicado: (2019)

Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis
por: Kobayashi, Taku, et al.
Publicado: (2020)

Development of algorithms for identifying patients with Crohn’s disease in the Japanese health insurance claims database
por: Morikubo, Hiromu, et al.
Publicado: (2021)

Performing colonoscopy before steroid induction is associated with shorter steroid use in patients with ulcerative colitis
por: Kobayashi, Taku, et al.
Publicado: (2023)

Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2022)

Validation of a claims‐based algorithm to identify cases of ulcerative colitis in Japan
por: Ogino, Haruei, et al.
Publicado: (2021)

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2022)

Cytomegalovirus Colitis in a Patient With Ulcerative Colitis on Vedolizumab Monotherapy
por: Meeralam, Yaser, et al.
Publicado: (2023)

Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
por: Yagisawa, Keiji, et al.
Publicado: (2019)

Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients
por: Yagisawa, Keiji, et al.
Publicado: (2020)

Microcarcinoid and Ulcerative Colitis: Case Report and Literature Review
por: Etienne, Denzil, et al.
Publicado: (2020)

Obstructive Giant Inflammatory Polyp of the Colon in Ulcerative Colitis
por: Alkhiari, Resheed, et al.
Publicado: (2023)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
por: Miyoshi, Jun, et al.
Publicado: (2018)

Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy
por: Takayama, Tetsuro, et al.
Publicado: (2015)

Relationship between Ulcerative Colitis and Rheumatoid Arthritis: A Review
por: Attalla, Mark G, et al.
Publicado: (2019)

Laparoscopic Proctocolectomy With Transanal Total Mesorectal Excision for Ulcerative Colitis
por: Ashitomi, Yuya, et al.
Publicado: (2021)

Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19
por: Mounsif, Sara, et al.
Publicado: (2022)

Ulcerative Colitis Flare Post Isotretinoin Use: A Case Report
por: AlHussein, Maha, et al.
Publicado: (2023)

Newly Diagnosed Ulcerative Colitis in the Third Trimester: A Case Report
por: Rodriguez, Arley K, et al.
Publicado: (2023)

Trends and Complication Rates in Ulcerative Colitis Patients With and Without Helicobacter pylori Infections
por: Kahlam, Aaron, et al.
Publicado: (2023)

Extensive Unprovoked Thromboembolism in Steroid-Dependent Ulcerative Colitis: A Case Report
por: Arshad, Hassaan, et al.
Publicado: (2023)

Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis: A Retrospective Analysis
por: Malakar, Sayan, et al.
Publicado: (2023)

Infliximab-Induced Non-specific Interstitial Pneumonitis in a Patient With Ulcerative Colitis (UC)
por: Nasir, Syed Alishan, et al.
Publicado: (2022)

A New Onset of Ulcerative Colitis Post-COVID-19: A Case Report
por: Xia, Chenfan, et al.
Publicado: (2023)

Mucosal concentrations of N‐acetyl‐5‐aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine
por: Fukuda, Tomohiro, et al.
Publicado: (2020)

Persistent Afebrile Abdominal Pain: An Unusual Case of Segmental Colitis in an Immunocompromised Host
por: Papakonstantinou, Ilias P, et al.
Publicado: (2017)

Refractory Fulminant Colitis Requiring Surgical Intervention in a Patient With Ulcerative Colitis on Atezolizumab Therapy for Small Cell Lung Cancer: An Atypical Case
por: Steiger, Stephanie, et al.
Publicado: (2022)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Degenerative Ulcerative Colitis After One Year of Evolution in a 20-Year-Old Patient
por: Ouryemchi, Mouad, et al.
Publicado: (2021)

Ileo-Anal Pouch Anastomosis and New Remedial Approaches for Ulcerative Colitis: A Review Article
por: Jankar, Abhijeet, et al.
Publicado: (2023)

Previously Untreated Ulcerative Colitis With Newly Diagnosed Primary Sclerosing Cholangitis: A Case Report
por: Tekeste, Rahel, et al.
Publicado: (2023)

Multi-omics analysis reveals the interaction of gut microbiome and host microRNAs in ulcerative colitis
por: Ma, Lingyan, et al.
Publicado: (2023)

Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2023)

Post‐marketing analysis for biosimilar CT‐P13 in inflammatory bowel disease compared with external data of originator infliximab in Japan
por: Sagami, Shintaro, et al.
Publicado: (2021)

Intensive Frequent Granulocyte Adsorptive Apheresis Therapy for Acute Fulminant Ulcerative Colitis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2023)

Steroid Resistance/Dependence Might Be an Alarming Feature for Cytomegalovirus Infection Among Ulcerative Colitis Patients With Increased Disease Activity
por: Gerçeker, Emre, et al.
Publicado: (2022)

Extent of disease affects the usefulness of fecal biomarkers in ulcerative colitis
por: Sakuraba, Akihito, et al.
Publicado: (2021)

Effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting in patients with Crohn’s disease or ulcerative colitis
por: Gheorghe, Cristian, et al.
Publicado: (2019)

5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis
por: Wada, Haruka, et al.
Publicado: (2023)

Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h3ln4nnb3i15tm58hq921tfosv